116 related articles for article (PubMed ID: 9917088)
1. Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer.
Chung TD; Mauceri HJ; Hallahan DE; Yu JJ; Chung S; Grdina WL; Yajnik S; Kufe DW; Weichselbaum RR
Cancer Gene Ther; 1998; 5(6):344-9. PubMed ID: 9917088
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.
Staba MJ; Mauceri HJ; Kufe DW; Hallahan DE; Weichselbaum RR
Gene Ther; 1998 Mar; 5(3):293-300. PubMed ID: 9614548
[TBL] [Abstract][Full Text] [Related]
3. Increased injection number enhances adenoviral genetic radiotherapy.
Mauceri HJ; Seung LP; Grdina WL; Swedberg KA; Weichselbaum RR
Radiat Oncol Investig; 1997; 5(5):220-6. PubMed ID: 9372544
[TBL] [Abstract][Full Text] [Related]
4. CV706, a prostate cancer-specific adenovirus variant, in combination with radiotherapy produces synergistic antitumor efficacy without increasing toxicity.
Chen Y; DeWeese T; Dilley J; Zhang Y; Li Y; Ramesh N; Lee J; Pennathur-Das R; Radzyminski J; Wypych J; Brignetti D; Scott S; Stephens J; Karpf DB; Henderson DR; Yu DC
Cancer Res; 2001 Jul; 61(14):5453-60. PubMed ID: 11454691
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.
Mauceri HJ; Hanna NN; Wayne JD; Hallahan DE; Hellman S; Weichselbaum RR
Cancer Res; 1996 Oct; 56(19):4311-4. PubMed ID: 8813113
[TBL] [Abstract][Full Text] [Related]
6. Combining radiation therapy with interstitial radiation-inducible TNF-α expression for locoregional cancer treatment.
Jung M; Dimtchev A; Velena A; Dritschilo A
Cancer Gene Ther; 2011 Mar; 18(3):189-95. PubMed ID: 21052099
[TBL] [Abstract][Full Text] [Related]
7. An adenovirus encoding proapoptotic Bax induces apoptosis and enhances the radiation effect in human ovarian cancer.
Arafat WO; Gómez-Navarro J; Xiang J; Barnes MN; Mahasreshti P; Alvarez RD; Siegal GP; Badib AO; Buchsbaum D; Curiel DT; Stackhouse MA
Mol Ther; 2000 Jun; 1(6):545-54. PubMed ID: 10933979
[TBL] [Abstract][Full Text] [Related]
8. Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity.
Dilley J; Reddy S; Ko D; Nguyen N; Rojas G; Working P; Yu DC
Cancer Gene Ther; 2005 Aug; 12(8):715-22. PubMed ID: 15832172
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of TNF-alpha effects on radiation efficacy in a human lung adenocarcinoma model.
Gridley DS; Andres ML; Garner C; Mao XW; Slater JM
Oncol Res; 1996; 8(12):485-95. PubMed ID: 9160352
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel enhanced radiation sensitization for the suppression of human prostate cancer tumor growth via a p53 independent pathway.
Zhang AL; Russell PJ; Knittel T; Milross C
Prostate; 2007 Nov; 67(15):1630-40. PubMed ID: 17823933
[TBL] [Abstract][Full Text] [Related]
11. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
[TBL] [Abstract][Full Text] [Related]
12. Combination of pGL1-TNF-alpha gene and radiation (proton and gamma-ray) therapy against brain tumor.
Gridley DS; Li J; Kajioka EH; Andres ML; Moyers MF; Slater JM
Anticancer Res; 2000; 20(6B):4195-203. PubMed ID: 11205248
[TBL] [Abstract][Full Text] [Related]
13. Cancer gene therapy using a novel secretable trimeric TRAIL.
Kim CY; Jeong M; Mushiake H; Kim BM; Kim WB; Ko JP; Kim MH; Kim M; Kim TH; Robbins PD; Billiar TR; Seol DW
Gene Ther; 2006 Feb; 13(4):330-8. PubMed ID: 16195699
[TBL] [Abstract][Full Text] [Related]
14. Combined ionizing radiation and sKDR gene delivery for treatment of prostate carcinomas.
Kaliberov SA; Kaliberova LN; Buchsbaum DJ
Gene Ther; 2005 Mar; 12(5):407-17. PubMed ID: 15616600
[TBL] [Abstract][Full Text] [Related]
15. Alpha1-adrenoceptor antagonists radiosensitize prostate cancer cells via apoptosis induction.
Cuellar DC; Rhee J; Kyprianou N
Anticancer Res; 2002; 22(3):1673-9. PubMed ID: 12168853
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral vaccination of adenoviruses expressing fusion protein RM4/tumor necrosis factor (TNF)-alpha induces significant tumor regression.
Wright P; Zheng C; Moyana T; Xiang J
Cancer Gene Ther; 1998; 5(6):371-9. PubMed ID: 9917092
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy targeted by radiation preferentially radiosensitizes tumor cells.
Weichselbaum RR; Hallahan DE; Beckett MA; Mauceri HJ; Lee H; Sukhatme VP; Kufe DW
Cancer Res; 1994 Aug; 54(16):4266-9. PubMed ID: 8044769
[TBL] [Abstract][Full Text] [Related]
18. TNFerade Biologic: preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene.
Rasmussen H; Rasmussen C; Lempicki M; Durham R; Brough D; King CR; Weichselbaum R
Cancer Gene Ther; 2002 Nov; 9(11):951-7. PubMed ID: 12386834
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pGL1-TNF-alpha therapy in combination with radiation.
Li J; Andres ML; Fodor I; Nelson GA; Gridley DS
Oncol Res; 1998; 10(7):379-87. PubMed ID: 10063972
[TBL] [Abstract][Full Text] [Related]
20. Combined effect of tumor necrosis factor-alpha and ionizing radiation on the induction of apoptosis in 5637 bladder carcinoma cells.
Baierlein SA; Distel L; Sieber R; Weiss C; Rödel C; Sauer R; Rödel F
Strahlenther Onkol; 2006 Aug; 182(8):467-72. PubMed ID: 16896593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
